The PennZone

PHILADELPHIA, Dec. 2, 2024 ~ IntegriChain, a leading provider of pharma revenue optimization technology and insights for the pharmaceutical industry, has announced that its distribution experts will be presenting at Informa's Trade & Channel Strategies conference in Philadelphia from December 10-12.

The conference will feature keynote speaker Bill Roth, Senior Vice President and Managing Partner of the Blue Fin Group, an IntegriChain Company, and Mike Zubey, Senior Vice President of Sales for IntegriChain. Both speakers bring extensive experience and insights in distribution strategies for pharmaceutical manufacturers of all sizes, business stages, and complexity.

Roth's keynote presentation titled "Access and Channel 2024 Year in Review and Preview of 2025" will take place on Tuesday, December 10 from 8:15-9:15 am ET. He will discuss the critical developments in access and channel for the year 2024 and provide a strategic outlook for 2025. Attendees can expect to gain a comprehensive understanding of the current reimbursement landscape, including key changes, challenges, and opportunities. Roth will also delve into how site-of-care trends are impacting patient access and channel dynamics. Additionally, he will analyze the influence of cost of goods on channel strategies and profitability while highlighting emerging trends and best practices.

More on The PennZone

• COLORICH PACKAGING Will Participate in the COSME Week 2025 TOKYO and Cosmoprof Worldwide Bologna 2025 Exhibition
• Hyperion Bancshares: Q4 Most Profitable Quarter
• IntellaTriage Launches New Patient Engagement Service
• Momentum Stock Trading: AI-Driven by Tickeron
• IntellaTriage Launches New Patient Engagement Service

On Wednesday, December 11 from 11:30 am-12:15 pm ET, Zubey will present "Leveraging Artificial Intelligence to Drive Channel Insights." As Senior Vice President of Pre-Commercial Customers and Launch Readiness at IntegriChain, Zubey brings considerable expertise on the role of artificial intelligence in life sciences. His session will explore how pharmaceutical companies can effectively govern and analyze their data by consolidating it from various sources into a single reliable location for both short- and long-term decision making. Zubey will also discuss traditional obstacles to therapy and how machine learning and artificial intelligence can uncover unseen correlations in data to improve care and adherence.

IntegriChain's sessions at the conference promise to provide valuable insights and strategies for pharmaceutical manufacturers looking to optimize their distribution processes. Attendees can expect to gain a deeper understanding of the current landscape and emerging trends in the industry, as well as practical solutions for improving profitability and patient care.

---

Show All News | Report Violation